ABCG2 (Q9UNQ0) variants and mutations
ABCG2 (also known as Q9UNQ0) is a human protein-coding gene encoding a broad substrate specificity ATP-binding cassette transporter protein. It exports many drugs, metabolites, urate, and dietary compounds from cells and is active at intestinal, hepatic, renal, placental, and barrier tissues. Functional variation can alter drug disposition and uric-acid handling, while overexpression can promote multidrug resistance. This analysis covers 1,023 ABCG2 variants and mutations. Of these, 75% have computational variant effect predictions. Disease context includes gout, hyperuricemia, and arthropathy. Example ABCG2 variants include S2F, S3C, and N5S.
Variant analysis overview
- Gene: ABCG2
- Protein: Q9UNQ0
- UniProt accession: Q9UNQ0
- Organism: Homo sapiens
- Variants analyzed: 1023
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 843 unspecified-consequence records; 101 missense variants; 45 synonymous variants; 10 stop-gained variants; 5 in-frame deletions; 15 frameshift variants; 1 splice-region variants; 1 in-frame insertions; 2 substitution
- Prediction scores: 771 variants have prediction scores (75% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: gout, hyperuricemia, arthropathy, Abnormality of the skeletal system, nephrolithiasis, urolithiasis, crystal arthropathy, Abnormality of blood and blood-forming tissues, ureterolithiasis, bladder calculus, bursitis, breast cancer.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 2 domains; 4 binding sites; 2 post-translational modification sites.
- Structural context: 830 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ABCG2 variants
Examples include S2F, S3C, N5S, V6G, E7D, E7K, V8A, V8F. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2F (p.Ser2Phe), cosmic curated COSV52949, gnomAD rs1212086865, REVEL 0.36, CADD 24.40
- S3C (p.Ser3Cys), TOPMed rs1725518703, REVEL 0.29, CADD 24.20
- N5S (p.Asn5Ser), ESP rs372490271, TOPMed rs372490271, gnomAD rs372490271, REVEL 0.07, CADD 10.30
- V6G (p.Val6Gly), gnomAD rs1388119295, REVEL 0.34, CADD 4.75
- E7D (p.Glu7Asp), rs747453638, NCI-TCGA Cosmic COSV9941, cosmic curated COSV99418, ExAC rs747453638, REVEL 0.15, CADD 6.83, Variant assessed as somatic; moderate impact.
- E7K (p.Glu7Lys), rs1272411168, NCI-TCGA Cosmic COSV5294, cosmic curated COSV52948, TOPMed rs1272411168, REVEL 0.24, CADD 12.90, Variant assessed as somatic; moderate impact.
- V8A (p.Val8Ala), ESP rs149877053, ExAC rs149877053, TOPMed rs149877053, gnomAD rs149877053, REVEL 0.24, CADD 19.30
- V8F (p.Val8Phe), ExAC rs774014561, TOPMed rs774014561, gnomAD rs774014561, REVEL 0.26, CADD 15.50
- V8G (p.Val8Gly), ESP rs149877053, ExAC rs149877053, TOPMed rs149877053, gnomAD rs149877053, REVEL 0.36, CADD 20.90
- V8I (p.Val8Ile), rs774014561, ExAC rs774014561, TOPMed rs774014561, gnomAD rs774014561, REVEL 0.12, CADD 12.10, Variant assessed as somatic; moderate impact.
- P11L (p.Pro11Leu), gnomAD rs930748886, REVEL 0.31, CADD 22.20
- P11S (p.Pro11Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V12A (p.Val12Ala), ExAC rs779729082, TOPMed rs779729082, gnomAD rs779729082, REVEL 0.16, CADD 22.70
- V12E (p.Val12Glu), ExAC rs779729082, TOPMed rs779729082, gnomAD rs779729082, REVEL 0.29, CADD 23.00
- V12M (p.Val12Met), rs2231137, ClinGen CA129174, cosmic curated COSV52945, ClinVar RCV000023337, REVEL 0.18, CADD 2.36, Likely benign; Affects; association, ABCG2-related disorder; BLOOD GROUP, JUNIOR SYSTEM; URIC ACID CONCENTRATION, SER
- S13L (p.Ser13Leu), rs1319203095, UniProt VAR 067363, TOPMed rs1319203095, REVEL 0.22, CADD 19.90
- Q14K (p.Gln14Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N16D (p.Asn16Asp), Ensembl rs1560706429, REVEL 0.09, CADD 8.23
- T17A (p.Thr17Ala), gnomAD rs1313475538, REVEL 0.20, CADD 5.28
- T17S (p.Thr17Ser), gnomAD rs1313475538, REVEL 0.13, CADD 3.43
- N18D (p.Asn18Asp), ExAC rs745666147
- G19D (p.Gly19Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P21S (p.Pro21Ser), cosmic curated COSV52946, TOPMed rs1256207467
- A22T (p.Ala22Thr), cosmic curated COSV52945, 1000Genomes rs191389789, ESP rs191389789, ExAC rs191389789, REVEL 0.30, CADD 0.12
- A22V (p.Ala22Val), rs139903768, ESP rs139903768, ExAC rs139903768, TOPMed rs139903768, REVEL 0.22, CADD 1.99, Variant assessed as somatic; moderate impact.
- T23I (p.Thr23Ile), TOPMed rs1725510660, REVEL 0.17, CADD 0.83
- A24P (p.Ala24Pro), TOPMed rs1181605596, gnomAD rs1181605596, REVEL 0.11, CADD 5.43
- A24T (p.Ala24Thr), cosmic curated COSV10510, TOPMed rs1181605596, gnomAD rs1181605596, REVEL 0.13, CADD 0.61
- S25C (p.Ser25Cys), Ensembl rs911128576
- S25F (p.Ser25Phe), Ensembl rs911128576, REVEL 0.15, CADD 15.20
- N26D (p.Asn26Asp), ExAC rs758463101, gnomAD rs758463101, REVEL 0.11, CADD 10.70
- N26K (p.Asn26Lys), TOPMed rs1725508954
- N26S (p.Asn26Ser), cosmic curated COSV52945, 1000Genomes rs373683219, ESP rs373683219, ExAC rs373683219, REVEL 0.10, CADD 0.46
- D27H (p.Asp27His), Ensembl rs987146842, REVEL 0.25, CADD 19.00
- L28P (p.Leu28Pro), TOPMed rs1425581427, gnomAD rs1425581427, REVEL 0.20, CADD 0.93
- L28V (p.Leu28Val), Ensembl rs1725508520
- K29N (p.Lys29Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K29R (p.Lys29Arg), TOPMed rs1196892045, gnomAD rs1196892045, REVEL 0.11, CADD 9.25
- A30S (p.Ala30Ser), NCI-TCGA Cosmic COSV5294, cosmic curated COSV52949, Variant assessed as somatic; moderate impact.
- A30T (p.Ala30Thr), Ensembl rs1560706245, REVEL 0.12, CADD 0.17
- A30V (p.Ala30Val), Ensembl rs947797678
- F31L (p.Phe31Leu), ExAC rs765475846, gnomAD rs765475846, REVEL 0.14, CADD 0.00
- T32I (p.Thr32Ile), Ensembl rs1725506732, REVEL 0.16, CADD 4.87
- V36A (p.Val36Ala), ESP rs146004187, ExAC rs146004187, TOPMed rs146004187, gnomAD rs146004187, REVEL 0.32, CADD 23.40
- V36G (p.Val36Gly), ESP rs146004187, ExAC rs146004187, TOPMed rs146004187, gnomAD rs146004187
- F39V (p.Phe39Val), rs2476286757, ClinGen CA357634599, ClinVar RCV004134620, Uncertain significance, not specified
- H40L (p.His40Leu), TOPMed rs1348206890, gnomAD rs1348206890, REVEL 0.56, CADD 25.70
- H40R (p.His40Arg), TOPMed rs1348206890, gnomAD rs1348206890, REVEL 0.41, CADD 23.20
- H40Y (p.His40Tyr), Ensembl rs561122328, REVEL 0.41, CADD 22.40
- N41D (p.Asn41Asp), Ensembl rs746161650, REVEL 0.26, CADD 19.10
- I42T (p.Ile42Thr), TOPMed rs1725504587
- I42V (p.Ile42Val), ExAC rs777059441, gnomAD rs777059441, REVEL 0.37, CADD 22.00
- Y44C (p.Tyr44Cys), TOPMed rs1337337886, gnomAD rs1337337886, REVEL 0.82, CADD 27.50
- Y44H (p.Tyr44His), TOPMed rs1439504107, gnomAD rs1439504107, REVEL 0.74, CADD 26.80
- R45* (p.Arg45Ter), rs761288842, NCI-TCGA Cosmic COSV5294, cosmic curated COSV52949, ExAC rs761288842, CADD 36.00, Variant assessed as somatic; high impact.
- R45G (p.Arg45Gly), ExAC rs761288842, TOPMed rs761288842, gnomAD rs761288842, REVEL 0.30, CADD 22.50
- R45Q (p.Arg45Gln), rs142634180, cosmic curated COSV52943, NCI-TCGA Cosmic COSV9941, ESP rs142634180, REVEL 0.09, CADD 18.30, Variant assessed as somatic; moderate impact.
- V46I (p.Val46Ile), TOPMed rs1725503352
- S50G (p.Ser50Gly), gnomAD rs1171922894, REVEL 0.22, CADD 21.90
- S50N (p.Ser50Asn), TOPMed rs1725502407, REVEL 0.21, CADD 19.30
- G51A (p.Gly51Ala), TOPMed rs1436625518, gnomAD rs1436625518, REVEL 0.57, CADD 24.40
- G51C (p.Gly51Cys), TOPMed rs1725502159
- F52L (p.Phe52Leu), 1000Genomes rs200372186
- C55Y (p.Cys55Tyr), Ensembl rs1560706058
- R56* (p.Arg56Ter), rs201034377, NCI-TCGA Cosmic COSV5294, cosmic curated COSV52948, 1000Genomes rs201034377, CADD 36.00, Variant assessed as somatic; high impact.
- R56L (p.Arg56Leu), 1000Genomes rs543249891, ExAC rs543249891, TOPMed rs543249891, gnomAD rs543249891
- R56Q (p.Arg56Gln), rs543249891, NCI-TCGA Cosmic COSV5294, cosmic curated COSV52943, 1000Genomes rs543249891, REVEL 0.15, CADD 15.80, Variant assessed as somatic; moderate impact.
- K61R (p.Lys61Arg), ExAC rs769486810, TOPMed rs769486810, gnomAD rs769486810, REVEL 0.34, CADD 22.80
- E62* (p.Glu62Ter), NCI-TCGA TCGA novel, CADD 37.00, Variant assessed as somatic; high impact.
- E62K (p.Glu62Lys), ExAC rs745441428, gnomAD rs745441428, REVEL 0.19, CADD 21.80
- I63V (p.Ile63Val), gnomAD rs1354560892, REVEL 0.09, CADD 16.40
- S65L (p.Ser65Leu), rs780975480, NCI-TCGA Cosmic COSV5294, cosmic curated COSV52945, ExAC rs780975480, REVEL 0.19, CADD 11.10, Variant assessed as somatic; moderate impact.
- S65P (p.Ser65Pro), TOPMed rs1725498652, REVEL 0.30, CADD 15.20
- N66I (p.Asn66Ile), ExAC rs746978396, gnomAD rs746978396, REVEL 0.43, CADD 23.50
- I67M (p.Ile67Met), NCI-TCGA Cosmic COSV9941, cosmic curated COSV99418, Variant assessed as somatic; moderate impact.
- N68Y (p.Asn68Tyr), TOPMed rs1294004492, REVEL 0.57, CADD 26.30
- I70F (p.Ile70Phe), TOPMed rs781446745, REVEL 0.38, CADD 23.80, Uncertain significance, not specified
- M71K (p.Met71Lys), gnomAD rs1321490321, REVEL 0.86, CADD 26.30
- M71V (p.Met71Val), 1000Genomes rs148475733, ESP rs148475733, ExAC rs148475733, TOPMed rs148475733, REVEL 0.60, CADD 24.80, Likely benign, not provided
- P73A (p.Pro73Ala), gnomAD rs1392737731, REVEL 0.52, CADD 25.20
- G74D (p.Gly74Asp), ExAC rs199976573, TOPMed rs199976573, gnomAD rs199976573, REVEL 0.87, CADD 25.70
- G74S (p.Gly74Ser), TOPMed rs1397059546, gnomAD rs1397059546, REVEL 0.91, CADD 29.00
- G74V (p.Gly74Val), ExAC rs199976573, TOPMed rs199976573, gnomAD rs199976573, REVEL 0.91, CADD 25.90
- L75F (p.Leu75Phe), rs746782619, cosmic curated COSV99420, ExAC rs746782619, TOPMed rs746782619, REVEL 0.50, CADD 25.30, Variant assessed as somatic; moderate impact.
- N76S (p.Asn76Ser), TOPMed rs1366180487, gnomAD rs1366180487, REVEL 0.69, CADD 25.70
- A77S (p.Ala77Ser), ExAC rs747978861, TOPMed rs747978861, gnomAD rs747978861
- A77T (p.Ala77Thr), ExAC rs747978861, TOPMed rs747978861, gnomAD rs747978861, REVEL 0.83, CADD 25.70
- I78V (p.Ile78Val), TOPMed rs1724971978, REVEL 0.41, CADD 24.00
- G80E (p.Gly80Glu), cosmic curated COSV52945, 1000Genomes rs569310717, ExAC rs569310717, TOPMed rs569310717, REVEL 0.98, CADD 25.10
- G80R (p.Gly80Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P81L (p.Pro81Leu), ESP rs144647749, ExAC rs144647749, TOPMed rs144647749, gnomAD rs144647749, REVEL 0.89, CADD 27.10
- T82I (p.Thr82Ile), ExAC rs754154859, gnomAD rs754154859, REVEL 0.92, CADD 26.80
- G83S (p.Gly83Ser), Ensembl rs1724970242
- G83V (p.Gly83Val), ExAC rs780404007, gnomAD rs780404007, REVEL 0.95, CADD 24.80
- G84A (p.Gly84Ala), Ensembl rs1052764540
- S87C (p.Ser87Cys), TOPMed rs1336655580
- S88L (p.Ser88Leu), rs200415908, cosmic curated COSV52943, ESP rs200415908, ExAC rs200415908, REVEL 0.51, CADD 22.80, Variant assessed as somatic; moderate impact.
- S88W (p.Ser88Trp), ESP rs200415908, ExAC rs200415908, TOPMed rs200415908, gnomAD rs200415908, REVEL 0.75, CADD 25.00
- L90S (p.Leu90Ser), TOPMed rs1724916319
- D91E (p.Asp91Glu), ExAC rs761492726, gnomAD rs761492726, REVEL 0.56, CADD 23.80
- D91G (p.Asp91Gly), cosmic curated COSV52946, TOPMed rs755380197, gnomAD rs755380197, REVEL 0.79, CADD 28.00
- A94V (p.Ala94Val), ExAC rs774407286, gnomAD rs774407286
- A95S (p.Ala95Ser), Ensembl rs1012607910, REVEL 0.36, CADD 25.30
- R96G (p.Arg96Gly), ESP rs149339865, ExAC rs149339865, gnomAD rs149339865, REVEL 0.82, CADD 26.10
- R96M (p.Arg96Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K97E (p.Lys97Glu), gnomAD rs1316542758, REVEL 0.66, CADD 26.40
- K97I (p.Lys97Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K97N (p.Lys97Asn), TOPMed rs1368759015, gnomAD rs1368759015, REVEL 0.49, CADD 23.40
- P99A (p.Pro99Ala), TOPMed rs1305398818, gnomAD rs1305398818, REVEL 0.55, CADD 24.40, Uncertain significance, not specified
- P99S (p.Pro99Ser), rs1305398818, TOPMed rs1305398818, gnomAD rs1305398818, REVEL 0.55, CADD 25.00, Variant assessed as somatic; moderate impact.
- P99T (p.Pro99Thr), NCI-TCGA TCGA novel, REVEL 0.58, CADD 25.30, Variant assessed as somatic; moderate impact.
- S100G (p.Ser100Gly), 1000Genomes rs551022147, ExAC rs551022147, gnomAD rs551022147, REVEL 0.24, CADD 9.74
- S100N (p.Ser100Asn), ExAC rs775730528, TOPMed rs775730528, gnomAD rs775730528, REVEL 0.12, CADD 1.66
- G104R (p.Gly104Arg), gnomAD rs1376744646, REVEL 0.95, CADD 25.20
- D105G (p.Asp105Gly), TOPMed rs1724910246, gnomAD rs1724910246, REVEL 0.53, CADD 24.00
- V106F (p.Val106Phe), Ensembl rs1724909895
- L107M (p.Leu107Met), NCI-TCGA Cosmic COSV9941, Variant assessed as somatic; moderate impact.
- L107V (p.Leu107Val), cosmic curated COSV99418, ExAC rs746120760, TOPMed rs746120760, gnomAD rs746120760
- I108T (p.Ile108Thr), TOPMed rs1361699841, gnomAD rs1361699841, REVEL 0.91, CADD 25.00
- G110A (p.Gly110Ala), ESP rs375251410, ExAC rs375251410, TOPMed rs375251410, gnomAD rs375251410, REVEL 0.75, CADD 24.20
- G110E (p.Gly110Glu), cosmic curated COSV52948, ESP rs375251410, ExAC rs375251410, TOPMed rs375251410, REVEL 0.86, CADD 24.50
- A111T (p.Ala111Thr), ExAC rs757687597, TOPMed rs757687597, gnomAD rs757687597, REVEL 0.34, CADD 21.50
- P112L (p.Pro112Leu), cosmic curated COSV52942, 1000Genomes rs199473672, ESP rs199473672, ExAC rs199473672, REVEL 0.30, CADD 16.30
- P112Q (p.Pro112Gln), cosmic curated COSV99419, 1000Genomes rs199473672, ESP rs199473672, ExAC rs199473672, REVEL 0.42, CADD 19.90
- R113* (p.Arg113Ter), rs201121511, NCI-TCGA Cosmic COSV9942, cosmic curated COSV99420, ExAC rs201121511, CADD 33.00, Variant assessed as somatic; high impact.
- R113Q (p.Arg113Gln), rs755591361, NCI-TCGA Cosmic COSV5294, cosmic curated COSV52944, ExAC rs755591361, REVEL 0.16, CADD 7.65, Variant assessed as somatic; moderate impact.
- P114H (p.Pro114His), TOPMed rs1724901463, REVEL 0.69, CADD 24.60
- P114T (p.Pro114Thr), TOPMed rs1724901822
- F117L (p.Phe117Leu), NCI-TCGA TCGA novel, TOPMed rs1312055972, gnomAD rs1312055972, REVEL 0.30, CADD 24.30, Variant assessed as somatic; moderate impact.
- K118N (p.Lys118Asn), ExAC rs767066657, gnomAD rs767066657, REVEL 0.25, CADD 23.70
- K118T (p.Lys118Thr), Ensembl rs1724900774
- C119R (p.Cys119Arg), Ensembl rs1724900084
- C119Y (p.Cys119Tyr), gnomAD rs1330286500, REVEL 0.69, CADD 25.20
- S121L (p.Ser121Leu), TOPMed rs1724899066
- G122C (p.Gly122Cys), cosmic curated COSV99419, TOPMed rs1292996300, gnomAD rs1292996300, REVEL 0.59, CADD 27.10
- G122D (p.Gly122Asp), Ensembl rs1724897908
- G122S (p.Gly122Ser), TOPMed rs1292996300, gnomAD rs1292996300
- V124L (p.Val124Leu), ExAC rs774024199, TOPMed rs774024199, gnomAD rs774024199, REVEL 0.88, CADD 25.10
- V124M (p.Val124Met), ExAC rs774024199, TOPMed rs774024199, gnomAD rs774024199, REVEL 0.91, CADD 25.80
- Q126* (p.Gln126Ter), rs72552713, ClinGen CA129172, ClinVar RCV000023335, ClinVar RCV000023336, CADD 41.00, association
- D127G (p.Asp127Gly), Ensembl rs1724849620, REVEL 0.94, CADD 29.20
- D127N (p.Asp127Asn), TOPMed rs1724849858
- D128E (p.Asp128Glu), ESP rs375846189, ExAC rs375846189, TOPMed rs375846189, gnomAD rs375846189, REVEL 0.57, CADD 22.50
- D128V (p.Asp128Val), 1000Genomes rs149106245, ExAC rs149106245, TOPMed rs149106245, gnomAD rs149106245, REVEL 0.79, CADD 25.60
- D128Y (p.Asp128Tyr), Ensembl rs2110040241
- V129A (p.Val129Ala), TOPMed rs1724848848
- M131I (p.Met131Ile), rs759726272, ExAC rs759726272, TOPMed rs759726272, gnomAD rs759726272, REVEL 0.40, CADD 24.70, Variant assessed as somatic; moderate impact.
- M131V (p.Met131Val), cosmic curated COSV10877, Ensembl rs2110040200, REVEL 0.44, CADD 24.80
- G132V (p.Gly132Val), TOPMed rs1026965987, gnomAD rs1026965987, REVEL 0.88, CADD 23.10
- T133A (p.Thr133Ala), gnomAD rs1439799804, REVEL 0.86, CADD 26.00
- L134R (p.Leu134Arg), TOPMed rs1724846670
- L134V (p.Leu134Val), NCI-TCGA Cosmic COSV9941, cosmic curated COSV99419, TOPMed rs1724846906, REVEL 0.34, CADD 19.90, Variant assessed as somatic; moderate impact.
- T135K (p.Thr135Lys), NCI-TCGA Cosmic COSV9941, NCI-TCGA Cosmic COSV9942, cosmic curated COSV99420, Variant assessed as somatic; moderate impact.
- T135M (p.Thr135Met), cosmic curated COSV99419, ExAC rs770985871, gnomAD rs770985871, REVEL 0.69, CADD 26.50
- V136M (p.Val136Met), ExAC rs773393258, gnomAD rs773393258, REVEL 0.46, CADD 24.90
- R137G (p.Arg137Gly), gnomAD rs1724845435, REVEL 0.95, CADD 27.40
- R137K (p.Arg137Lys), cosmic curated COSV52949, ExAC rs748501399, gnomAD rs748501399, REVEL 0.76, CADD 24.40
- R137T (p.Arg137Thr), rs748501399, NCI-TCGA Cosmic COSV5294, ExAC rs748501399, gnomAD rs748501399, REVEL 0.92, CADD 24.90, Variant assessed as somatic; moderate impact.
- E138* (p.Glu138Ter), NCI-TCGA Cosmic COSV5294, cosmic curated COSV52944, NCI-TCGA Cosmic COSV9941, Variant assessed as somatic; high impact.
- E138K (p.Glu138Lys), rs961438533, NCI-TCGA Cosmic COSV5294, NCI-TCGA Cosmic COSV9941, REVEL 0.55, CADD 27.50, Variant assessed as somatic; moderate impact.
- E138Q (p.Glu138Gln), NCI-TCGA Cosmic COSV5294, cosmic curated COSV52945, NCI-TCGA Cosmic COSV9941, Variant assessed as somatic; moderate impact.
- N139S (p.Asn139Ser), Ensembl rs1724844478, REVEL 0.43, CADD 25.20
- L140* (p.Leu140Ter), Ensembl rs1578209464
- L140F (p.Leu140Phe), TOPMed rs1724843141, REVEL 0.25, CADD 21.40
- L140V (p.Leu140Val), rs1265942342, NCI-TCGA Cosmic COSV5294, cosmic curated COSV52943, TOPMed rs1265942342, REVEL 0.23, CADD 20.50, Variant assessed as somatic; moderate impact.
- Q141* (p.Gln141Ter), 1000Genomes rs2231142, ESP rs2231142, ExAC rs2231142, TOPMed rs2231142, Benign
- Q141E (p.Gln141Glu), 1000Genomes rs2231142, ESP rs2231142, ExAC rs2231142, TOPMed rs2231142, REVEL 0.06, CADD 16.40, Benign
- Q141K (p.Gln141Lys), rs2231142, Civic 260, ClinGen CA129179, cosmic curated COSV52943, REVEL 0.11, CADD 19.70, drug response, rosuvastatin response - Efficacy; rosuvastatin response - Metabolism/PK
- Q141P (p.Gln141Pro), ExAC rs769050167, gnomAD rs769050167, REVEL 0.19, CADD 25.60
- S143A (p.Ser143Ala), gnomAD rs1346765745
- S143L (p.Ser143Leu), Ensembl rs1724841605, REVEL 0.67, CADD 29.70
- S143P (p.Ser143Pro), gnomAD rs1346765745, REVEL 0.71, CADD 27.50
- A144E (p.Ala144Glu), NCI-TCGA Cosmic COSV5294, cosmic curated COSV52942, Variant assessed as somatic; moderate impact.
- A144V (p.Ala144Val), Ensembl rs2110040039
- A145P (p.Ala145Pro), TOPMed rs947226023, gnomAD rs947226023, REVEL 0.28, CADD 26.10
- A145T (p.Ala145Thr), TOPMed rs947226023, gnomAD rs947226023, REVEL 0.16, CADD 25.70
- R147Q (p.Arg147Gln), ExAC rs780594297, TOPMed rs780594297, gnomAD rs780594297, REVEL 0.55, CADD 27.20
- R147W (p.Arg147Trp), rs372192400, cosmic curated COSV52942, UniProt VAR 082302, ESP rs372192400, REVEL 0.63, CADD 31.00, Benign
- L148P (p.Leu148Pro), gnomAD rs1389663757, REVEL 0.84, CADD 27.70
- A149P (p.Ala149Pro), 1000Genomes rs201006821, ExAC rs201006821, TOPMed rs201006821, gnomAD rs201006821, REVEL 0.12, CADD 18.60
Public ABCG2 analysis runs
- ABCG2 analysis run — ABCG2 (1,023 variants) — completed 2026-08-18